We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Instem Plc | LSE:INS | London | Ordinary Share | GB00B3TQCK30 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 830.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMINS
RNS Number : 8034V
Instem plc
19 April 2021
Instem plc
("Instem" or "the Company")
Holding(s) in Company
Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, announces that on 16 April 2021, DWT Holdings, Inc ("DWTH") notified the Company of its interest in 868,203 ordinary shares of ten pence each in the capital of the Company (the "Ordinary Shares"), representing 3.99 per cent. of the Company's total voting rights.
As previously announced, the Ordinary Shares were issued to DWTH as part of the consideration for the acquisition of d-Wise Technologies, Inc ("d-Wise") which legally completed on 1 April 2021, with the Ordinary Shares being admitted to trading on AIM on 14 April 2021. DWTH will, in due course, transfer these Ordinary Shares to the two d-wise founding shareholders and 16 further employees.
A Standard form for notification of major holdings (TR1) can be found at the foot of this announcement.
For further information, please contact:
Instem plc Via Walbrook Phil Reason, CEO Nigel Goldsmith, CFO N+1 Singer (Nominated Adviser & Broker) +44 (0) 20 7496 3000 Peter Steel Alex Bond Rachel Hayes Walbrook Financial PR +44 (0) 20 7933 8780 Tom Cooper instem@walbrookpr.com Nick Rome Nicholas Johnson
About Instem
Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection; Regulatory Solutions for Submissions and Compliance; and Informatics-based Insight Generation.
Instem solutions are in use by over 600 customers worldwide, including all the largest 25 pharmaceutical companies, enabling clients to bring life enhancing products to market faster. Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.
Instem products and services address aspects of the entire drug development value chain, from discovery through to market launch. Management estimate that over 50% of all drugs on the market have been through some part of Instem's platform at some stage of their development.
To learn more about Instem solutions and its mission, please visit www.instem.com
TR-1: S tandard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) (i) 1a. Identity of the issuer or the Instem plc underlying issuer of existing shares to which voting rights are attached (ii) : -------------------------------------------- 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) Non-UK issuer ---- 2. Reason for the notification (please mark the appropriate box or boxes with an "X") An acquisition or disposal of voting rights X ---- An acquisition or disposal of financial instruments ---- An event changing the breakdown of voting rights ---- Other (please specify) (iii) : ---- 3. Details of person subject to the notification obligation (iv) Name DWT Holdings, Inc City and country of registered office Asheville, USA (if applicable) 4. Full name of shareholder(s) (if different from 3.) (v) Name -------------------------------------------- City and country of registered office (if applicable) -------------------------------------------- 5. Date on which the threshold was 14/04/2021 crossed or reached (vi) : -------------------------------------------- 6. Date on which issuer notified (DD/MM/YYYY): 16/04/2021 -------------------------------------------- 7. Total positions of person(s) subject to the notification obligation % of voting % of voting rights Total of both Total number rights attached through financial in % (8.A + of voting rights to shares (total instruments 8.B) held in issuer of 8. A) (total of 8.B (8.A + 8.B) 1 + 8.B 2) (vii) ------------------ --------------------- -------------- -------------------- Resulting situation on the date on which threshold was crossed or reached 3.99% - 3.99% 868,203 ------------------ --------------------- -------------- -------------------- Position of - - - previous notification (if applicable) ------------------ --------------------- -------------- -------------------- 8. Notified details of the resulting situation on the date on which the threshold was crossed or reached (viii) A: Voting rights attached to shares Class/type of Number of voting rights % of voting rights shares (ix) ISIN code (if possible) Direct Indirect Direct Indirect (DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1) ---------------------- Ordinary GB00B3TQCK30 868,203 3.99% --------------------- ---------------------- -------------------- ---------------- SUBTOTAL 8. A 868,203 3.99% --------------------------------------------- -------------------------------------- B 1: Financial Instruments according to DTR5.3.1R (1) (a) Type of financial Expiration Exercise/ Number of voting % of voting instrument date Conversion Period rights that may rights (x) (xi) be acquired if the instrument is exercised/converted. ----------- -------------------------- -------------------------- ---------------- SUBTOTAL 8. B 1 -------------------------- -------------------------- ---------------- B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b) Type of financial Expiration Exercise/ Physical or Number of % of voting instrument date (x) Conversion cash voting rights rights Period (xi) Settlement (xii) ---------------- ---------------- ------------------- --------------- SUBTOTAL 8.B.2 ------------------- --------------- 9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X") Person subject to the notification obligation is not controlled X by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (xiii) Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) (xiv) Name (xv) % of voting rights % of voting rights Total of both if if it equals or through financial it equals or is is higher than the instruments if it higher than the notifiable threshold equals or is higher notifiable threshold than the notifiable threshold ---------------------- --------------------- ------------------------ 10. In case of proxy voting, please identify: Name of the proxy holder N/A
----------------------------------------------- The number and % of voting rights N/A held ----------------------------------------------- The date until which the voting rights N/A will be held ----------------------------------------------- 11. Additional information (xvi) Place of completion Off-market Date of completion 15/04/2021 -----------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
HOLUBURRAVUSAAR
(END) Dow Jones Newswires
April 19, 2021 02:00 ET (06:00 GMT)
1 Year Instem Chart |
1 Month Instem Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions